vTv Therapeutics Q3 EPS $(0.94) Beats $(1.09) Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Beats
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.94) per share which beat the analyst consensus estimate of $(1.09) by 13.76 percent. This is a 12.96 percent increase over losses of $(1.08) per share from
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.94) per share which beat the analyst consensus estimate of $(1.09) by 13.76 percent. This is a 12.96 percent increase over losses of $(1.08) per share from the same period last year.